# Fuso Chemical

Fuso Chemical is a Corporate Investor based in Osaka-shi, Japan.

## Overview

- **Organization type:** Corporate Investor
- **Headquarters:** Osaka-shi, Japan
- **Region:** Asia
- **Address:** 3-5-29, Kitahama, Chuo-ku, Osaka, 541-0041, Japan
- **Founded:** 1949
- **Assets under management:** Undisclosed
- **Website:** chengxinfuso.co.jp
- **LinkedIn:** https://www.linkedin.com/company/fuso-chemical-co-ltd

## Regulatory record

- **Reports private funds:** No

## About

Fuso Chemical was founded in 1949 and has operated as a corporate investor from its base in Osaka, Japan, where the Akazawa family still holds direct and indirect control through entities like Kunpusha Co., Ltd. Representative Director and Chairman Misako Fujioka leads the firm's strategic direction from its dual headquarters in Osaka's Nippon Life Yodoyabashi Building and Tokyo's Ogura Building. The firm's wealth is tied directly to its operating history manufacturing high-purity chemical products for the electronics and pharmaceutical industries — a business that earned it recognition as a Global Niche Top Company by Japan's Ministry of Economy, Trade and Industry. Investment activity is concentrated in pharmaceutical intermediates, life-science tools, and specialty chemicals, with a focus on companies that complement Fuso's own six industrial and R&D sites across Ibaraki, Kyoto, Osaka, Kobe, and Kawasaki. The firm uses its corporate balance sheet rather than a dedicated fund structure, taking direct stakes in technology partners. While specific portfolio companies are not publicly itemized, the strategic relationship with Teikoku Seiyaku Co., Ltd. — a 13.The presence of GIC on the shareholder register marks the firm as a target for sovereign co-investment, unusual for a chemical company of its scale. Fuso Chemical supplements its commercial operations with two foundations — the FUSO Innovative Technology Fund and the FUSO Scholarship Foundation — that extend its influence into academic research and talent development. These vehicles operate alongside the core corporate entity, supporting long-term technology pipelines without blurring the line between investment and philanthropy. The firm's team size is not publicly disclosed, but its footprint spans two headquarters, five production and R&D sites, and two designated forest properties in Tokyo and Kagawa Prefecture. Fuso Chemical's structural differentiator is its hybrid posture as a public company with family control and a sovereign co-investor. That configuration gives it permanent capital and a patient-investor mandate, allowing it to fund emerging technologies in specialty chemicals and life sciences without the fundraising cycle that constrains venture funds. The Akazawa family's ongoing stewardship, combined with the operational partnership with Teikoku Seiyaku, creates a closed-loop system where equity, R&D collaboration, and supply-chain integration reinforce each other.

## Sectors

- Industrial Tech
- Healthcare Services

## Offices

- 6-6, Nihonbashi-kobuna-cho, Chuo-ku, Tokyo, 103-0024, Japan

## People

- Misako Fujioka — Representative Director & Chairman

## Questions

### Who runs investment decisions at Fuso Chemical?

Representative Director and Chairman Misako Fujioka leads strategic capital allocation, operating from dual headquarters in Osaka and Tokyo. Investment decisions are made within the corporate structure rather than through a separate fund-management entity, reflecting Fuso's status as a corporate investor deploying its own balance sheet.

### Why does GIC hold a stake in Fuso Chemical?

Singapore's GIC holds a 4.32% stake in Fuso Chemical, positioning the sovereign wealth fund as a passive co-investor. The presence of GIC on the shareholder register signals institutional confidence in Fuso's niche industrial position and its pharmaceutical-adjacent growth strategy — a rare configuration for a mid-cap Japanese chemical company.

### What is Fuso Chemical's known posture on co-investments?

Fuso Chemical invests directly from its corporate balance sheet and does not operate a formal fund structure. Co-investment occurs through strategic shareholder relationships — notably with Teikoku Seiyaku — rather than through syndicated venture rounds, giving the firm a relationship-driven rather than market-driven deployment style.

## Related profiles

- [Fusion Analytics Investment Partners](https://altss.com/profile/fusion-analytics-investment-partners)
- [Futu Wealth Advisors](https://altss.com/profile/futu-wealth-advisors)

---

Last updated: 2026-08-11T02:43:31.692Z

Canonical page: https://altss.com/profile/fuso-chemical

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology